Rebiotix Inc is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating gastrointestinal (GI) diseases by harnessing the power of the human microbiome. The company is on the forefront of an exciting potential medical breakthrough, Microbiota Restoration Therapy (MRT). MRT is the Rebiotix Drug Platform for delivering healthy, live, human-derived microbes into a sick patient’s intestinal tract to treat disease. Rebiotix looks to deliver on the promise of restoring the gut microbiota via a standardized and stabilized drug that has been developed and tested under the auspices of a regulatory authority.
Roseville, US
Size (employees)
39 (est)+3%
Rebiotix was founded in 2011 and is headquartered in Roseville, US
Report incorrect company information

Key People/Management at Rebiotix

Lee Jones

Lee Jones

Erwin Kelen

Erwin Kelen


Rebiotix Office Locations

Rebiotix has an office in Roseville
Roseville, US (HQ)
2660 Patton Rd
Show all (1)
Report incorrect company information

Rebiotix Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$27.8 m

Latest funding size

$25 m

Time since last funding

4 years ago
Rebiotix's latest funding round in August 2014 was reported to be $25 m. In total, Rebiotix has raised $27.8 m
Show all financial metrics
Report incorrect company information

Rebiotix News and Updates

Hepatic Encephalopathy: Market competition to grow in forecast period due to foray of more players with their unique quality of simplifying the market research study presents a deep diving study report “Hepatic Encephalopathy - Pipeline Review, H1 2018” Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information